Detalles de la búsqueda
1.
How I treat older patients with DLBCL in the frontline setting.
Blood
; 141(21): 2566-2575, 2023 05 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36413153
2.
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study.
Blood
; 141(14): 1675-1684, 2023 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36542826
3.
Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study.
Blood
; 140(9): 1009-1019, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35544601
4.
Plain language summary of the TRANSFORM study primary analysis results: lisocabtagene maraleucel as a second treatment regimen for large B-cell lymphoma following failure of the first treatment regimen.
Future Oncol
; 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38547003
5.
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.
Lancet
; 399(10343): 2294-2308, 2022 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35717989
6.
COVID-19-associated immune thrombocytopenia.
Br J Haematol
; 190(2): e61-e64, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32420612
7.
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities.
JCO Oncol Pract
; 19(3): e407-e416, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36508702
8.
Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA.
J Hematol Oncol
; 16(1): 104, 2023 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37705050
9.
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.
Cancers (Basel)
; 15(22)2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001703
10.
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study.
EClinicalMedicine
; 61: 102040, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37337616
11.
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
Cancers (Basel)
; 15(17)2023 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37686611
12.
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.
Lancet Haematol
; 10(12): e966-e975, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37922925
13.
Diminished amplification of SARS-CoV-2 ORF1ab in a commercial dual-target qRT-PCR diagnostic assay.
J Virol Methods
; 300: 114397, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34863783
14.
Health-related quality of life with lisocabtagene maraleucel vs standard of care in relapsed or refractory LBCL.
Blood Adv
; 6(23): 5969-5979, 2022 12 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36149968
15.
Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis.
Eur J Cancer
; 176: 100-109, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36208568
16.
Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach.
Cancers (Basel)
; 14(8)2022 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35454765
17.
Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients.
PLoS One
; 17(8): e0271807, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35960720
18.
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19.
JAMA Oncol
; 8(10): 1477-1483, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35951338
19.
Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium.
Eur J Cancer
; 160: 261-272, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34799210
20.
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients.
Blood Adv
; 6(5): 1537-1546, 2022 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35114690